B. Metzler seel. Sohn & Co. AG Sells 2,295 Shares of DaVita Inc. $DVA

Key Points

• B. Metzler seel. Sohn & Co. AG reduced its holdings in DaVita Inc. by 47.1%, selling 2,295 shares and owning 2,574 shares worth $394,000 following the sale.
• Several institutional investors, including Iron Triangle Partners and GAMMA Investing LLC, have significantly altered their positions in DaVita, contributing to 90.12% institutional ownership of the company.
• DaVita's recent earnings report showed an EPS of $2.95, exceeding estimates, with a revenue increase of 6.1% year-over-year, and the company has set FY 2025 guidance of 10.200-11.300 EPS.

B. Metzler seel. Sohn & Co. AG lowered its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 47.1% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 2,574 shares of the company's stock after selling 2,295 shares during the period. B. Metzler seel. Sohn & Co. AG's holdings in DaVita were worth $394,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Fifth Third Bancorp raised its stake in shares of DaVita by 5.0% during the first quarter. Fifth Third Bancorp now owns 4,274 shares of the company's stock valued at $654,000 after acquiring an additional 204 shares during the last quarter. Concurrent Investment Advisors LLC bought a new position in shares of DaVita during the first quarter valued at $223,000. Wealth Enhancement Advisory Services LLC raised its stake in shares of DaVita by 22.5% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 4,351 shares of the company's stock valued at $666,000 after acquiring an additional 800 shares during the last quarter. Envestnet Asset Management Inc. increased its position in shares of DaVita by 7.9% during the first quarter. Envestnet Asset Management Inc. now owns 55,255 shares of the company's stock worth $8,452,000 after buying an additional 4,048 shares during the period. Finally, OneDigital Investment Advisors LLC acquired a new stake in shares of DaVita during the first quarter worth $200,000. Institutional investors own 90.12% of the company's stock.

DaVita Stock Down 0.8%

Shares of NYSE DVA traded down $1.12 during mid-day trading on Wednesday, reaching $135.83. 583,942 shares of the company's stock traded hands, compared to its average volume of 851,361. The stock has a market cap of $9.71 billion, a P/E ratio of 13.36, a PEG ratio of 0.99 and a beta of 1.13. The business has a 50-day simple moving average of $139.59 and a 200 day simple moving average of $142.20. DaVita Inc. has a 1-year low of $126.07 and a 1-year high of $179.60. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.39 and a quick ratio of 1.34.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $2.95 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.70 by $0.25. The firm had revenue of $3.38 billion during the quarter, compared to analysts' expectations of $3.36 billion. DaVita had a net margin of 6.35% and a return on equity of 369.39%. The business's revenue was up 6.1% on a year-over-year basis. During the same period last year, the company earned $2.00 earnings per share. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. On average, analysts expect that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Insider Activity

In related news, insider James O. Hearty sold 2,351 shares of the firm's stock in a transaction dated Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total transaction of $352,650.00. Following the transaction, the insider directly owned 26,038 shares of the company's stock, valued at $3,905,700. This trade represents a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.50% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on DVA. Truist Financial set a $148.00 price objective on shares of DaVita in a research report on Friday, August 8th. Barclays decreased their price objective on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a research report on Thursday, August 7th. Finally, Wall Street Zen upgraded shares of DaVita from a "hold" rating to a "buy" rating in a research report on Friday, August 22nd. Three investment analysts have rated the stock with a Hold rating, According to MarketBeat, the company has an average rating of "Hold" and an average target price of $164.00.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.